India's Largest Database on New Projects
Johnson & Johnson to acquire Synthes
28 April 2011: Johnson & Johnson (J&J), a global healthcare products manufacturer, is likely to acquire global manufacturer of orthopaedic devices Synthes Inc for $21.3 billion (approx Rs 9,372 crore) in a cash and stock deal.
Both the companies have entered into a definitive agreement whereby J&J will acquire Synthes for CHF 159 per share or $21.3 billion. The transaction is expected to close during the first half of 2012. The transaction is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act, approval by the European Commission and regulatory approval in certain other jurisdictions, as well as other customary closing conditions.
Synthes is widely respected for its innovative, high quality products, research and development capabilities, its commitment to education, the highest standards of service and extensive global footprint.
Source: Hindu Business Line